Bayesian Capital Management’s Archrock AROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,900
Closed -$207K 544
2025
Q1
$207K Sell
7,900
-11,400
-59% -$308K 0.03% 483
2024
Q4
$480K Buy
+19,300
New +$447K 0.06% 379
2024
Q3
Sell
-13,300
Closed -$269K 666
2024
Q2
$269K Buy
+13,300
New +$264K 0.03% 532
2020
Q2
Sell
-13,795
Closed -$52K 524
2020
Q1
$52K Buy
+13,795
New +$99.6K 0.01% 724
2019
Q2
Sell
-11,906
Closed -$116K 506
2019
Q1
$116K Buy
+11,906
New +$114K 0.02% 503
2018
Q2
Sell
-10,736
Closed -$94K 587
2018
Q1
$94K Buy
+10,736
New +$103K 0.02% 532

Other funds holding AROC

Bayesian Capital Management's AROC Position: Q2 2025 in Review

Bayesian Capital Management sold out of Archrock (AROC) in Q2 2025, closing a stake of 7,900 shares — an estimated $207K sold.

Bayesian Capital Management first reported a position in AROC in Q1 2018 and held it in 6 quarters. The position peaked at $480K in Q4 2024. 372 funds tracked by Wall St. Rank hold AROC as of Q2 2025.

  • Bayesian Capital Management reported no remaining Archrock position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 7,900 Archrock shares in Q2 2025, an estimated $207K.
  • Bayesian Capital Management first reported a position in Archrock in Q1 2018 and held it in 6 quarters.
  • Bayesian Capital Management's Archrock position peaked at $480K in Q4 2024.
  • 372 funds tracked by Wall St. Rank held Archrock as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.